language_icon
EN
HI

Godavari Drugs Share price

GODAVARI

92

0.78 (-0.84%)
Last updated on 2 Apr, 2026 | 15:28 IST
Today's High

100.00

Today's Low

90.26

52 Week Low

69.70

52 Week High

115.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Godavari Drugs Chart

Godavari Drugs Share Key Metrics

Volume
26972.00
Market Cap
69.87 CR
LTQ@LTP
26@92.00
ATP
95.53
Var Margin
25.43 %
Circuit Range
74.23-111.33
Delivery %
95.76 %
Value
25.77 L
ASM/GSM
No
Market Lot
1

Summary

At 2 Apr, 2026 | 15:28, Godavari Drugs share price stands at ₹92, showing a 0.78% -0.84 for the day. The stock’s intraday movement has stayed between ₹90.26 and ₹100.00, while on a 52-week basis it has fluctuated from ₹69.70 to ₹115.00.
In terms of trading activity, Godavari Drugs has recorded a volume of 26972 shares, with a market capitalisation of ₹7530500. The stock’s Average Traded Price (ATP) stands at ₹9553, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 26,9200. The stock operates within a circuit range of ₹74.23-111.33, with a Value of ₹25.77 L. The Delivery Percentage for the day is 95.76%. Additionally, Godavari Drugs currently falls under the No framework, and trades with a market lot size of 1.

Godavari Drugs Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

60.59

Sector P/B

3.25

Sec. Div. Yield

0.59

Godavari Drugs Resistance and Support

Pivot 90.94

Resistance

First Resistance

96.74

Second Resistance

100.7

Third Resistance

106.5

Support

First Support

86.98

Second Support

81.18

Third Support

77.22

Godavari Drugs Futures & Options

Data Not Found

Godavari Drugs Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

54%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0.5%

Retail

45.51%

Others

-0.01%

Total Promoters
MAR '18
54%
JUN '18
53.99%
SEP '18
54%
DEC '18
54%

Godavari Drugs Corporate Actions

DateAgenda
2026-02-11Quarterly Results
2026-01-15Preferential issue of shares
2025-11-14Quarterly Results
2025-08-13Quarterly Results & A.G.M.
2025-05-29Audited Results
2025-02-12Quarterly Results

Godavari Drugs News

Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Prashant Shrimal, part of Godavari Drugs' Promoter Group, acquired 1,12,360 equity shares through a preferential issue. This transaction, dated March 18, 2026, increased the promoter's holding by 1.11% of the total voting capital.
Mar 23 2026 12:03:00

Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Promoter Mohit Jaju acquired 4,00,065 convertible warrants from Godavari Drugs Limited via preferential allotment on March 18, 2026. This transaction increased his total diluted shareholding in the company to 7.29%.
Mar 20 2026 18:03:00
Read More

About Godavari Drugs

NSE : 0  
BSE : 530317  
ISIN : INE362C01012  

GODAVARI DRUGS LIMITED was incorporated as a private limited company on December 2nd 1987 and subsequently converted into a public limited company on September 25th 1992. It was promoted by Mr. Ghanshyam Jaju Mr. Mukund Kakani and Mr. P.C. Shrimal. The company has set up a project to manufacture 180 TPA at SULPHAMETHOXAZOLE (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC) Nanded a notified class ''C'' backward district in Maharashtra. The project was fully commissioned on July 3rd 1989.MAIN OBJECTS OF THE COMPANY:The main objects at the Company as detailed in the Memorandum at Association of the Company are:1. To manufacture refine purchase sell prepare import export all classes and kinds of drugs including pharmaceutical preparations and formulations fine organics and inorganic chemicals raw materials and intermediates for drugs.2. To manufacture and/or deal in all types at drugs chemicals pharmaceuticals and intermediates on loan licence basis. 3. To undertake promote encourage initiate assist and engage in all kinds of research and development work and to set up laboratories and other facilities required for the same to render such assistance monetary or otherwise as may be required for the purpose.

Read More

Godavari Drugs Management

NamePosition
Mr. Ghanshyam Jaju Chairman
Mr. Mukund Kakani Managing Director
View More

Godavari Drugs FAQs

The Buying Price of Godavari Drugs share is 92 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Godavari Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Godavari Drugs, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Godavari Drugs shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Godavari Drugs shares is 0. Useful to assess the stock's value relative to its book value.

To assess Godavari Drugs’s valuation compare Sector P/E, P/B which are 60.59 & 3.25 with sector averages, along with growth rates and financial metrics.

The Market Cap of Godavari Drugs is 69.87 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Godavari Drugs share price is 115.00 & 69.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Godavari Drugs belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost